Clinical Trial Update: The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluates intralesional botulinum toxin A and intralesional triamcinolone acetonide injections for treating keloid scars.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid Scarring

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Keloid Scars | Phase 2 | Status: ACTIVE_NOT_RECRUITING